BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Allert S, Schulz D, Kämmer P, Großmann P, Wolf T, Schäuble S, Panagiotou G, Brunke S, Hube B. From environmental adaptation to host survival: Attributes that mediate pathogenicity of Candida auris. Virulence 2022;13:191-214. [PMID: 35142597 DOI: 10.1080/21505594.2022.2026037] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 de Melo CC, de Sousa BR, da Costa GL, Oliveira MME, de Lima-neto RG. Colonized patients by Candida auris: Third and largest outbreak in Brazil and impact of biofilm formation. Front Cell Infect Microbiol 2023;13. [DOI: 10.3389/fcimb.2023.1033707] [Reference Citation Analysis]
2 Satala D, Juszczak M, Wronowska E, Surowiec M, Kulig K, Kozik A, Rapala-kozik M, Karkowska-kuleta J. Similarities and Differences among Species Closely Related to Candida albicans: C. tropicalis, C. dubliniensis, and C. auris. Cellular Microbiology 2022;2022:1-25. [DOI: 10.1155/2022/2599136] [Reference Citation Analysis]
3 Watkins RR, Gowen R, Lionakis M, Ghannoum M. Update on the Pathogenesis, Virulence, and Treatment of Candida auris. PAI 2022;7:46-65. [DOI: 10.20411/pai.v7i2.535] [Reference Citation Analysis]
4 Amatuzzi RF, Zamith-miranda D, Munhoz da Rocha IF, Lucena ACR, de Toledo Martins S, Streit R, Staats CC, Trentin G, Almeida F, Rodrigues ML, Nosanchuk JD, Alves LR. Caspofungin Affects Extracellular Vesicle Production and Cargo in Candida auris. JoF 2022;8:990. [DOI: 10.3390/jof8100990] [Reference Citation Analysis]
5 Sahu SR, Bose S, Singh M, Kumari P, Dutta A, Utkalaja BG, Patel SK, Acharya N. Vaccines against candidiasis: Status, challenges and emerging opportunity. Front Cell Infect Microbiol 2022;12:1002406. [DOI: 10.3389/fcimb.2022.1002406] [Reference Citation Analysis]
6 Jin L, Liu S, Tan S, Wang Y, Zhao Y, Yu S. Petrositis caused by fluconazole-resistant candida: case report and literature review. BMC Infect Dis 2022;22:649. [PMID: 35896968 DOI: 10.1186/s12879-022-07637-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Schrevens S, Durandau E, Tran VDT, Sanglard D. Using in vivo transcriptomics and RNA enrichment to identify genes involved in virulence of Candida glabrata. Virulence 2022. [PMID: 35795910 DOI: 10.1080/21505594.2022.2095716] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Riera FO, Caeiro JP, Angiolini SC, Vigezzi C, Rodriguez E, Icely PA, Sotomayor CE. Invasive Candidiasis: Update and Current Challenges in the Management of This Mycosis in South America. Antibiotics 2022;11:877. [DOI: 10.3390/antibiotics11070877] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Sanyaolu A, Okorie C, Marinkovic A, Abbasi AF, Prakash S, Mangat J, Hosein Z, Haider N, Chan J. Candida auris: An Overview of the Emerging Drug-Resistant Fungal Infection. Infect Chemother 2022;54:236-46. [PMID: 35794716 DOI: 10.3947/ic.2022.0008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Stieber H, Junghanns L, Wilhelm H, Batliner M, Aldejohann AM, Kurzai O, Martin R. The sphingolipid inhibitor myriocin increases susceptibility of Candida auris to amphotericin B.. [DOI: 10.1101/2022.04.14.488279] [Reference Citation Analysis]